[Sclerotherapy].
D004305:Dose-Response Relationship, Drug; D006801:Humans; D011379:Prognosis; D012597:Sclerosing Solutions / Q000009:adverse effects / Q000627:therapeutic use*; D014648:Varicose Veins / Q000175:diagnosis / Q000628:therapy*
D012597:Sclerosing Solutions
Aspekte zur Sklerotherapie.